These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29092754)

  • 21. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size.
    Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
    Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and treatment outcome of multiple primary lung cancer patients with different imaging performance].
    Chen K; Wang X; Yang F; Zhao H; Li Y; Liu Y; Zhou Z; Jiang G; Li J; Liu J; Wang J
    Zhonghua Wai Ke Za Zhi; 2015 Oct; 53(10):731-6. PubMed ID: 26654303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors of lung adenocarcinoma manifesting as ground glass nodules larger than 3 cm.
    Ding H; Wang H; Zhang P; Song N; Chen L; Jiang G
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1130-1135. PubMed ID: 30561606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What are the radiologic findings predictive of indolent lung adenocarcinoma?
    Mimae T; Miyata Y; Tsutani Y; Mimura T; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Apr; 45(4):367-72. PubMed ID: 25628349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with multiple nodules and a dominant lung adenocarcinoma have similar outcomes and survival compared with patients who have a solitary adenocarcinoma.
    Castiglioni M; Louie BE; Wilshire CL; Farivar AS; Aye RW; Gorden J; Horton MP; Vallières E
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):229-35. PubMed ID: 25376726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment is an effective approach for patients with synchronous multiple primary lung cancers.
    Peng Y; Ren W; Wang H; Li M; Feng Z; Peng Z
    J Cancer Res Ther; 2017; 13(4):702-706. PubMed ID: 28901318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.
    Suzuki K; Asamura H; Kusumoto M; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2002 Nov; 74(5):1635-9. PubMed ID: 12440622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Factors for Survival in Multiple Primary Lung Adenocarcinomas: A Retrospective Analysis of 283 Patients.
    Zheng Y; Han X; Wu Y; Jia X; Zhang K; Fan J; Shi H
    Technol Cancer Res Treat; 2023; 22():15330338231185278. PubMed ID: 37365877
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictors of primary lung cancer in a solitary pulmonary lesion after a previous malignancy.
    Nakadate A; Nakadate M; Sato Y; Nakagawa T; Yoshida K; Suzuki Y; Yoshida Y
    Gen Thorac Cardiovasc Surg; 2017 Dec; 65(12):698-704. PubMed ID: 28887727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
    Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
    Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
    PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
    Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
    Suzuki K; Watanabe SI; Wakabayashi M; Saji H; Aokage K; Moriya Y; Yoshino I; Tsuboi M; Nakamura S; Nakamura K; Mitsudomi T; Asamura H;
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):289-301.e2. PubMed ID: 33487427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.